US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist

17.335
+0.435+2.57%

Trading Dec 26 12:13 ET

2.29BMarket Cap-11.40P/E (TTM)

Centessa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

42.80%-21.39M

7.90%-40.58M

22.06%-37.29M

20.05%-160.34M

39.78%-31.05M

4.34%-37.39M

26.41%-44.06M

4.36%-47.84M

-200.55M

-51.56M

Net income from continuing operations

-10.14%-42.57M

-76.07%-43.82M

24.98%-38.05M

30.12%-151.09M

14.68%-36.84M

28.26%-38.65M

61.51%-24.89M

6.94%-50.71M

---216.21M

---43.17M

Depreciation and amortization

-0.84%236K

-0.42%236K

169.66%240K

518.32%810K

583.33%246K

580.00%238K

640.63%237K

217.86%89K

--131K

--36K

Deferred tax

143.39%1.25M

102.41%567K

--434K

-828.56%-26.53M

94.63%-149K

-2,040.74%-2.89M

---23.49M

--0

---2.86M

---2.77M

Other non cash items

----

-83.82%28K

---67K

----

--173K

----

Change In working capital

365.50%11.8M

-21.55%-5.88M

-47.80%-9.17M

-566.13%-18.86M

75.98%-3.37M

-162.97%-4.45M

-174.43%-4.84M

-164.52%-6.2M

---2.83M

---14.04M

-Change in receivables

523.90%9.84M

9.49%-5.56M

-71.92%1.21M

-3.25%-12.09M

-105.36%-7.94M

8.83%-2.32M

-1,534.81%-6.14M

175.17%4.31M

---11.71M

---3.86M

-Change in prepaid assets

261.77%4.01M

17.23%-1.49M

199.07%3.21M

63.45%-1.36M

123.26%1.85M

-174.32%-2.48M

-58.06%-1.81M

-46.67%1.07M

---3.73M

---7.94M

-Change in payables and accrued expense

-1,023.91%-2.13M

-78.88%1.1M

-17.97%-13.67M

-127.90%-3.52M

217.52%2.63M

-96.33%230K

-27.83%5.2M

-946.09%-11.58M

--12.61M

---2.24M

-Change in other current assets

-41.27%74K

103.58%75K

--76K

---1.88M

--85K

--126K

---2.09M

--0

Cash from discontinued investing activities

Operating cash flow

42.80%-21.39M

7.90%-40.58M

22.06%-37.29M

20.05%-160.34M

39.78%-31.05M

4.34%-37.39M

26.41%-44.06M

4.36%-47.84M

---200.55M

---51.56M

Investing cash flow

Cash flow from continuing investing activities

-7.68%44.96M

22.00%-55.46M

119.41%16.76M

-13,541.68%-127M

-3,997.53%-18.28M

304,512.50%48.71M

-30,947.60%-71.1M

-35,873.33%-86.34M

-931K

-446K

Net PPE purchase and sale

20.93%-34K

--0

85.14%-169K

95.71%-28K

-168.75%-43K

95.63%-10K

63.33%-88K

---1.14M

---652K

Net investment purchase and sale

-7.69%45M

21.99%-55.46M

119.43%16.76M

---126.84M

---18.25M

--48.75M

---71.09M

---86.25M

--0

Net other investing changes

----

--206K

----

Cash from discontinued investing activities

Investing cash flow

-7.68%44.96M

22.00%-55.46M

119.41%16.76M

-13,541.68%-127M

-3,997.53%-18.28M

304,512.50%48.71M

-30,947.60%-71.1M

-35,873.33%-86.34M

---931K

---446K

Financing cash flow

Cash flow from continuing financing activities

1,568.36%245.98M

877,508.33%105.31M

10.49M

4,520.79%21.12M

7,047.19%6.36M

6,482.14%14.74M

-82.86%12K

457K

89K

Net common stock issuance

1,566.49%242.71M

--107.27M

--9.66M

--20.81M

--6.24M

--14.56M

--0

Proceeds from stock option exercised by employees

2,258.33%4.25M

6,583.33%802K

--838K

-56.82%310K

32.58%118K

-19.64%180K

-82.86%12K

--0

--718K

--89K

Net other financing activities

---970K

----

---261K

--0

Cash from discontinued financing activities

Financing cash flow

1,568.36%245.98M

877,508.33%105.31M

--10.49M

4,520.79%21.12M

7,047.19%6.36M

6,482.14%14.74M

-82.86%12K

--0

--457K

--89K

Net cash flow

Beginning cash position

-12.29%127.37M

-54.53%118.22M

-67.48%128.03M

-33.85%393.64M

-61.45%171.5M

-70.01%145.22M

-52.25%259.99M

-33.85%393.64M

--595.08M

--444.84M

Current changes in cash

934.45%269.56M

108.05%9.27M

92.52%-10.03M

-32.44%-266.23M

17.25%-42.96M

167.02%26.06M

-91.80%-115.15M

-167.37%-134.17M

---201.02M

---51.92M

Effect of exchange rate changes

-965.45%-1.9M

-131.50%-120K

-57.72%219K

247.13%615K

-169.81%-504K

150.23%220K

242.16%381K

219.35%518K

---418K

--722K

End cash Position

130.34%395.03M

-12.29%127.37M

-54.53%118.22M

-67.48%128.03M

-61.45%171.5M

-70.01%145.22M

-52.25%259.99M

--393.64M

Free cash flow

42.77%-21.42M

7.92%-40.58M

22.20%-37.29M

20.41%-160.51M

40.48%-31.08M

4.27%-37.44M

26.68%-44.07M

4.64%-47.93M

---201.68M

---52.22M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	42.80%-21.39M	7.90%-40.58M	22.06%-37.29M	20.05%-160.34M	39.78%-31.05M	4.34%-37.39M	26.41%-44.06M	4.36%-47.84M	-200.55M	-51.56M
Net income from continuing operations	-10.14%-42.57M	-76.07%-43.82M	24.98%-38.05M	30.12%-151.09M	14.68%-36.84M	28.26%-38.65M	61.51%-24.89M	6.94%-50.71M	---216.21M	---43.17M
Depreciation and amortization	-0.84%236K	-0.42%236K	169.66%240K	518.32%810K	583.33%246K	580.00%238K	640.63%237K	217.86%89K	--131K	--36K
Deferred tax	143.39%1.25M	102.41%567K	--434K	-828.56%-26.53M	94.63%-149K	-2,040.74%-2.89M	---23.49M	--0	---2.86M	---2.77M
Other non cash items	----	----	----	-83.82%28K	---67K	----	----	----	--173K	----
Change In working capital	365.50%11.8M	-21.55%-5.88M	-47.80%-9.17M	-566.13%-18.86M	75.98%-3.37M	-162.97%-4.45M	-174.43%-4.84M	-164.52%-6.2M	---2.83M	---14.04M
-Change in receivables	523.90%9.84M	9.49%-5.56M	-71.92%1.21M	-3.25%-12.09M	-105.36%-7.94M	8.83%-2.32M	-1,534.81%-6.14M	175.17%4.31M	---11.71M	---3.86M
-Change in prepaid assets	261.77%4.01M	17.23%-1.49M	199.07%3.21M	63.45%-1.36M	123.26%1.85M	-174.32%-2.48M	-58.06%-1.81M	-46.67%1.07M	---3.73M	---7.94M
-Change in payables and accrued expense	-1,023.91%-2.13M	-78.88%1.1M	-17.97%-13.67M	-127.90%-3.52M	217.52%2.63M	-96.33%230K	-27.83%5.2M	-946.09%-11.58M	--12.61M	---2.24M
-Change in other current assets	-41.27%74K	103.58%75K	--76K	---1.88M	--85K	--126K	---2.09M	--0	--0	--0
Cash from discontinued investing activities
Operating cash flow	42.80%-21.39M	7.90%-40.58M	22.06%-37.29M	20.05%-160.34M	39.78%-31.05M	4.34%-37.39M	26.41%-44.06M	4.36%-47.84M	---200.55M	---51.56M
Investing cash flow
Cash flow from continuing investing activities	-7.68%44.96M	22.00%-55.46M	119.41%16.76M	-13,541.68%-127M	-3,997.53%-18.28M	304,512.50%48.71M	-30,947.60%-71.1M	-35,873.33%-86.34M	-931K	-446K
Net PPE purchase and sale	20.93%-34K	--0	--0	85.14%-169K	95.71%-28K	-168.75%-43K	95.63%-10K	63.33%-88K	---1.14M	---652K
Net investment purchase and sale	-7.69%45M	21.99%-55.46M	119.43%16.76M	---126.84M	---18.25M	--48.75M	---71.09M	---86.25M	--0	--0
Net other investing changes	----	----	----	----	----	----	----	----	--206K	----
Cash from discontinued investing activities
Investing cash flow	-7.68%44.96M	22.00%-55.46M	119.41%16.76M	-13,541.68%-127M	-3,997.53%-18.28M	304,512.50%48.71M	-30,947.60%-71.1M	-35,873.33%-86.34M	---931K	---446K
Financing cash flow
Cash flow from continuing financing activities	1,568.36%245.98M	877,508.33%105.31M	10.49M	4,520.79%21.12M	7,047.19%6.36M	6,482.14%14.74M	-82.86%12K	0	457K	89K
Net common stock issuance	1,566.49%242.71M	--107.27M	--9.66M	--20.81M	--6.24M	--14.56M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	2,258.33%4.25M	6,583.33%802K	--838K	-56.82%310K	32.58%118K	-19.64%180K	-82.86%12K	--0	--718K	--89K
Net other financing activities	---970K	----	----	----	----	----	----	----	---261K	--0
Cash from discontinued financing activities
Financing cash flow	1,568.36%245.98M	877,508.33%105.31M	--10.49M	4,520.79%21.12M	7,047.19%6.36M	6,482.14%14.74M	-82.86%12K	--0	--457K	--89K
Net cash flow
Beginning cash position	-12.29%127.37M	-54.53%118.22M	-67.48%128.03M	-33.85%393.64M	-61.45%171.5M	-70.01%145.22M	-52.25%259.99M	-33.85%393.64M	--595.08M	--444.84M
Current changes in cash	934.45%269.56M	108.05%9.27M	92.52%-10.03M	-32.44%-266.23M	17.25%-42.96M	167.02%26.06M	-91.80%-115.15M	-167.37%-134.17M	---201.02M	---51.92M
Effect of exchange rate changes	-965.45%-1.9M	-131.50%-120K	-57.72%219K	247.13%615K	-169.81%-504K	150.23%220K	242.16%381K	219.35%518K	---418K	--722K
End cash Position	130.34%395.03M	-12.29%127.37M	-54.53%118.22M	-67.48%128.03M	-67.48%128.03M	-61.45%171.5M	-70.01%145.22M	-52.25%259.99M	--393.64M	--393.64M
Free cash flow	42.77%-21.42M	7.92%-40.58M	22.20%-37.29M	20.41%-160.51M	40.48%-31.08M	4.27%-37.44M	26.68%-44.07M	4.64%-47.93M	---201.68M	---52.22M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data